RDNT Stock Overview
Provides outpatient diagnostic imaging services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
My Notes
Capture your thoughts, links and company narrative
RadNet, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$67.17 |
| 52 Week High | US$93.65 |
| 52 Week Low | US$35.16 |
| Beta | 1.8 |
| 1 Month Change | -5.42% |
| 3 Month Change | 3.27% |
| 1 Year Change | 81.69% |
| 3 Year Change | 156.96% |
| 5 Year Change | 198.33% |
| Change since IPO | 6,617.00% |
Recent News & Updates
Does RadNet (NASDAQ:RDNT) Have A Healthy Balance Sheet?
Jan 16
Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?
Jan 01There's Reason For Concern Over RadNet, Inc.'s (NASDAQ:RDNT) Massive 26% Price Jump
Nov 12Here's What To Make Of RadNet's (NASDAQ:RDNT) Decelerating Rates Of Return
Oct 15RadNet: Secular Tailwinds Underpinned By AI Monetization Prospects
Oct 02Recent updates
Does RadNet (NASDAQ:RDNT) Have A Healthy Balance Sheet?
Jan 16Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?
Jan 01There's Reason For Concern Over RadNet, Inc.'s (NASDAQ:RDNT) Massive 26% Price Jump
Nov 12Here's What To Make Of RadNet's (NASDAQ:RDNT) Decelerating Rates Of Return
Oct 15RadNet: Secular Tailwinds Underpinned By AI Monetization Prospects
Oct 02Unpleasant Surprises Could Be In Store For RadNet, Inc.'s (NASDAQ:RDNT) Shares
Sep 22RadNet: Growth In Operating Earnings Off Very Little Incremental Capital
Aug 24RadNet (NASDAQ:RDNT) Seems To Use Debt Quite Sensibly
Jul 22Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled
Jun 05RadNet: Qualified Growth Route, Still Undervalued
Jun 05Is There Now An Opportunity In RadNet, Inc. (NASDAQ:RDNT)?
May 10Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?
Apr 08RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues
Mar 06Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching
Feb 08RadNet, Inc. Stock Price Is More Vigorous Than Its Valuation
Jan 28RadNet JV acquires Montclair Radiology's outpatient radiology assets
Oct 11RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha
Aug 28RadNet Non-GAAP EPS of $0.15 beats by $0.06, revenue of $354.1M beats by $5.16M;reaffirms FY guidance
Aug 09Shareholder Returns
| RDNT | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 5.4% | 3.8% | -0.2% |
| 1Y | 81.7% | 1.6% | 23.7% |
Return vs Industry: RDNT exceeded the US Healthcare industry which returned 1.6% over the past year.
Return vs Market: RDNT exceeded the US Market which returned 23.7% over the past year.
Price Volatility
| RDNT volatility | |
|---|---|
| RDNT Average Weekly Movement | 7.5% |
| Healthcare Industry Average Movement | 8.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 18.8% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: RDNT has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: RDNT's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 8,157 | Howard Berger | www.radnet.com |
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
RadNet, Inc. Fundamentals Summary
| RDNT fundamental statistics | |
|---|---|
| Market cap | US$4.88b |
| Earnings (TTM) | -US$4.41m |
| Revenue (TTM) | US$1.77b |
2.8x
P/S Ratio-1,127x
P/E RatioIs RDNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RDNT income statement (TTM) | |
|---|---|
| Revenue | US$1.77b |
| Cost of Revenue | US$1.35b |
| Gross Profit | US$423.02m |
| Other Expenses | US$427.43m |
| Earnings | -US$4.41m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.06 |
| Gross Margin | 23.86% |
| Net Profit Margin | -0.25% |
| Debt/Equity Ratio | 91.1% |
How did RDNT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/29 00:48 |
| End of Day Share Price | 2025/01/29 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
RadNet, Inc. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sarah James | Barclays |
| Andrew Mok | Barclays |
| Juan Molta | B. Riley Securities, Inc. |